ReviewActa haematologica2024

Test Then Erase? Current Status and Future Opportunities for Measurable Residual Disease Testing in Acute Myeloid Leukemia.

Amanda L Blackmon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.